Supplemental Table 4 provides prevalence rates of any tobacco use using TNE-2 cut-points.
No takes yet. Share an insight, caveat, or question.
Edwards et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: